Evoke Pharma (EVOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Operating Expenses | 13,150 | 2,602 | 2,002 | 2,415 | 0 |
| Operating Income | -13,150 | -2,602 | -2,002 | -2,415 | N/A |
| Interest Expense | 0 | 160 | 24 | 3 | 0 |
| Other Income | -98 | -75 | 9 | 16 | 0 |
| Pre-tax Income | -13,248 | -2,837 | -2,018 | -2,401 | 0 |
| Net Income Continuous | -13,248 | -2,837 | -2,018 | -2,401 | N/A |
| Net Income | $-13,248 | $-2,837 | $-2,018 | $-2,401 | $N/A |
| EPS Basic Total Ops | -317.05 | -172.94 | -257.97 | -314.17 | N/A |
| EPS Basic Continuous Ops | -316.46 | -172.63 | -258.68 | -313.74 | N/A |
| EPS Diluted Total Ops | -317.05 | -172.94 | -257.97 | -314.17 | N/A |
| EPS Diluted Continuous Ops | -316.46 | -172.63 | -258.68 | -313.74 | N/A |
| EBITDA(a) | $-13,150 | $-2,602 | $-2,002 | $-2,415 | $N/A |